Malte Peters
Director/Board Member bei TANGO THERAPEUTICS, INC.
Vermögen: 39 700 $ am 31.03.2024
Profil
Malte Peters is currently the Director of Cancer Research at Merck KGAA Unsponsored ADR Facility, the Director at Tango Therapeutics Sub, Inc., the Independent Director at HOOKIPA Pharma, Inc., the Independent Non-Executive Director at HOOKIPA Pharma, Inc., and a Research Scientist at Amgen NV.
Previously, he worked as the Director of Cancer Research at Merck KGaA, the Medical Director at Micromet AG, the Head of Clinical and Site Head at Novartis AG, the Chief Research and Development Officer at MorphoSys AG, and the Global Head of Clinical Development at Sandoz International GmbH.
He obtained his doctorate degree from Freie Universität Berlin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TANGO THERAPEUTICS, INC.
0,00% | 06.06.2023 | 5 000 ( 0,00% ) | 39 700 $ | 31.03.2024 |
Aktive Positionen von Malte Peters
| Unternehmen | Position | Beginn |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Director/Board Member | 01.09.2018 |
| HOOKIPA PHARMA INC. | Director/Board Member | 01.01.2023 |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Director/Board Member | 10.10.2018 |
Amgen NV
 Amgen NV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen NV is a pharmaceutical company based in Diegem, Belgium. The Belgian company is focused on developing innovative therapies to address serious illnesses and improve the lives of patients. Amgen is committed to advancing scientific research and delivering high-quality medicines to patients worldwide. The CEO of the private company is Gabor Sztaniszlav. | Corporate Officer/Principal | - |
| Merck KGAA Unsponsored ADR Facility | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Malte Peters
| Unternehmen | Position | Ende |
|---|---|---|
| MORPHOSYS AG | Chief Tech/Sci/R&D Officer | 01.10.2022 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Corporate Officer/Principal | 01.02.2017 |
| NOVARTIS AG | Chief Tech/Sci/R&D Officer | 01.05.2015 |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Chief Tech/Sci/R&D Officer | 01.06.2004 |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Malte Peters
| Freie Universität Berlin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| MERCK KGAA | Health Technology |
| NOVARTIS AG | Health Technology |
| MORPHOSYS AG | Health Technology |
| HOOKIPA PHARMA INC. | Health Technology |
| TANGO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Merck KGAA Unsponsored ADR Facility | |
Micromet AG
Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Amgen NV
Amgen NV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen NV is a pharmaceutical company based in Diegem, Belgium. The Belgian company is focused on developing innovative therapies to address serious illnesses and improve the lives of patients. Amgen is committed to advancing scientific research and delivering high-quality medicines to patients worldwide. The CEO of the private company is Gabor Sztaniszlav. | Health Technology |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Health Technology |
